CareersInvestor RelationsPress RoomCOVID-19
  1. Home
  2. Laboratory Diagnostic Solutions India
  3. Molecular Diagnostics
  4. Molecular Diagnostics Tests & Reagents
  5. FTD Respiratory Pathogens 21 Assay
FTD Respiratory Pathogens 21 Assay

FTD Respiratory Pathogens 21 Assay

Syndromic testing for upper respiratory infections using multiplex RT-PCR

The FTD™ Respiratory pathogens 21 assay1 is a qualitative in vitro nucleic acid amplification test for the detection and differentiation of specific viral and bacterial nucleic acids in nasopharyngeal swab specimens of human origin.

The test is intended as an aid in the diagnosis of respiratory infections caused by influenza A virus (IAV), influenza A virus H1N1 swine-lineage (IAV [H1N1] swl), influenza B virus (IBV), human rhinovirus (HRV), human coronaviruses (HCoV) 229E, NL63, HKU1, and OC43, human parainfluenza viruses (HPIV) 1 through 4, human metapneumoviruses (HMPV) A and B, human bocavirus (HBoV), Mycoplasma pneumoniae (M. pneumoniae), human respiratory syncytial viruses (HRSV) A and B, human parechovirus (HPeV), enterovirus (EV), and human adenovirus (HAdV).

Clinical Use

Acute respiratory pathogen infections are common causes of acute local and systemic disease with substantial morbidity and mortality in pediatric, adult, and immunocompromised patients. Early and accurate diagnosis of respiratory pathogens diminishes transmission and complications. More efficient laboratory testing enables the physician to determine appropriate and timely patient treatment.2,3

Features & Benefits

  • Provides simultaneous detection of probable pathogens with one kit using a single sample for increased testing efficiency.
  • Syndromic assay enables testing of multiple pathogens at the same time, saving time and resources.4
  • Supports management of respiratory infections throughout the year as well as during seasonal peaks using the same protocol and solution.
  • Cost effective and easy to implement in any molecular laboratory.

Pathogens

Pathogens

Viruses

Influenza viruses

influenza A
influenza A H1N1 swine-lineage
influenza B

Respiratory syncytial viruses

human respiratory syncytial virus A and B

Parainfluenza viruses

parainfluenza virus 1
parainfluenza virus 2
parainfluenza virus 3
parainfluenza virus 4

Coronaviruses

coronavirus 229E
coronavirus HKU1
coronavirus NL63
coronavirus OC43

Picornaviruses

rhinovirus
enterovirus
parechovirus

Other respiratory viruses

metapneumovirus A and B
adenovirus
bocavirus

Bacteria

Mycoplasma pneumoniae

1

CE-marked for in vitro diagnostic use in the EU.

2

WHO, 2023

3

CDC, 2023

4

Ramanan et al., Syndromic Panel-Based Testing in Clinical Microbiology, CMR, 2018.